High Immunoreactivity of DUOX2 Is Associated With Poor Response to Preoperative Chemoradiation Therapy and Worse Prognosis in Rectal Cancers

Purpose: Colorectal cancer is the third most common cancer and also the fourth most common cause of cancer mortality worldwide. For rectal cancer, neoadjuvant concurrent chemoradiotherapy (CCRT) followed by radical proctectomy is gold standard treatment for patients with stage II/III rectal cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Shih-Chun, Chang, I-Wei, Hsieh, Pei-Ling, Lin, Ching-Yih, Sun, Ding-Ping, Sheu, Ming-Jen, Yang, Ching-Chieh, Lin, Li-Ching, He, Hong-Lin, Tian, Yu-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604207/
https://www.ncbi.nlm.nih.gov/pubmed/28928864
http://dx.doi.org/10.7150/jca.19545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604207/
https://www.ncbi.nlm.nih.gov/pubmed/28928864
http://dx.doi.org/10.7150/jca.19545

Ejemplares similares